Natalia Bondarenko


The aim of the research was analyze of C-reactive protein levels in serum blood samples during various periods of pregnancy in women, infected with parvovirus B19 and in case of presence of clinical complications.

129 pregnant women, infected with parvovirus B19 infection and 16 women with physiological pregnancy during first, second and third trimesters of pregnancy were examined. Depending on the presence or absence of clinical complications each group of pregnant women (I, II, III) was divided into two subgroups. The concentration of C-reactive protein in blood serum was determined by the method of immunoassay analysis using diagnostic sets of reagents (ELISA kits, USA). Statistical processing of data was carried out using the package of applied programs Microsoft Office Excel 2010 and StatSoft Statistica 6.1.

The mean age of pregnant woman in our study was 26±6 years. In the Iand II groups of infected B19 parvovirus pregnant women were identified a significant increasing of C-reactive protein levels compared to controls by 62.5 % and 50.0 % (p<0.05). The largest increasing of C-reactive protein level relative to control values was observed in women with clinical complications in different pregnancy periods (p<0.05).

An increase levels of the marker of systemic inflammation the C-reactive protein in the blood testifies to its active participation in the launch of a complex mechanism for the development of labor activity and the occurrence of fetal disorders, which was confirmed in groups of pregnant women with clinical complications in different periods of pregnancy.


pregnancy; parvovirus B19 infection; C-reactive protein

Full Text:



Ahushkova, L.M., Bulah, N. A., Moskalenko, N. P., Sukharev, A. E., Nikolaev, A. A. (2014). Izychenie С- reactivnogo protein pri beremennosti. Fundamentalnie issledovaniya, 4 (3), 619–623.

Francis, F., Bhat, V., Mondal, N., Adhisivam, B., Jacob, S., Dorairajan, G., Harish, B. N. (2017). Fetal inflammatory response syndrome (FIRS) and outcome of preterm neonates – a prospective analytical study. The Journal of Maternal-Fetal& Neonatal Medicine, 1–5. doi: 10.1080/14767058.2017.1384458

Shahshahan, Z., Rasouli, O. (2014). The use of maternal C-reactive protein in the predicting of preterm labor and tocolytic therapy in preterm labor women. Advanced Biomedical Research, 3 (1), 154. doi: 10.4103/2277-9175.137864

Chandrashekara, S. (2014). C-reactive protein: An inflammatory marker with specific role in physiology, pathology, and diagnosis. Internet Journal of Rheumatology and Clinical Immunology, 2. doi: 10.15305/ijrci/v2is1/117

Igipova, M. B., Serduk, G. V., Momot, A. P. (2010). Kliniko-diagnosticheskoe znachenie С-reactivnogo belka kak markera sistemnogovo spalitelnogo otveta pri beremennosti (obzorliteraturu). Klinicheskaya laboratornaya diagnostika, 6, 3–8.

Malek, A., Bersinger, N. A., Di Santo, S., Mueller, M. D., Sager, R., Schneider, H. et. al. (2006). C-Reactive Protein Production in Term Human Placental Tissue. Placenta, 27 (6-7), 619–625. doi: 10.1016/j.placenta.2005.05.009

Sacks, G. P., Syani, L., Lavery, S., Trew, G. (2004). Maternal C-reactive protein levels are raised at 4 weeks gestation. Human Reproduction, 19, 1025–1030. doi: 10.1093/humrep/deh179

Jauniaux, E., Gulbis, B., Jamil, A., Jurkovic, D. (2015). Evaluation of the role of maternal serum high-sensitivity C-reactive protein in predicting early pregnancy failure. Reproductive BioMedicine Online, 30 (3), 268–274. doi: 10.1016/j.rbmo.2014.11.009

Sharmin, S., Chy, S., Alam, D., Banu, N., Rashid, F., Kabir, S. (2017). Association of Serum C-reactive Protein in Preeclampsia and its Effect on Fetal Birth Weight – A Case Control Study. Bangladesh Journal of Obstetrics & Gynaecology, 31 (2), 75–80. doi: 10.3329/bjog.v31i2.34214

Tjoa, M. L., van Vugt, J. M. G., Go, A. T. J. J., Blankenstein, M. A., Oudejans, C. B. M., van Wijk, I. J. (2003). Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. Journal of Reproductive Immunology, 59 (1), 29–37. doi: 10.1016/s0165-0378(02)00085-2

Pitiphat, W., Gillman, M. W., Joshipura, K. J., Williams, P. L., Douglass, C. W., Rich-Edwards, J. W. (2005). Plasma C-Reactive Protein in Early Pregnancy and Preterm Delivery. American Journal of Epidemiology, 162 (11), 1108–1113. doi: 10.1093/aje/kwi323

Hvilsom, G., Thorsen, P., Jeune, B., Bakketeig, L. (2002). C-reactive protein: a serological marker for preterm delivery? ActaObstetriciaetGynecologicaScandinavica, 81 (5), 424–429. doi: 10.1034/j.1600-0412.2002.810509.x

Palasanthiran, P., Starr, M., Jones, C., Giles, M. (2014). Management of perinatal infections. Sydney: Australasian Society for Infectious Diseases (ASID) Inc., 90.

Peltier, M. R., Faux, D. S., Hamblin, S. D., Silver, R. M., Esplin, M. S. (2010). Cytokine production by peripheral blood mononuclear cells of women with a history of preterm birth. Journal of Reproductive Immunology, 84 (1), 111–116. doi: 10.1016/j.jri.2009.10.002

Lohsoonthorn, V., Qiu, C., Williams, M. A. (2007). Maternal serum C-reactive protein concentrations in early pregnancy and subsequent risk of preterm delivery. Clinical Biochemistry, 40 (5-6), 330–335. doi: 10.1016/j.clinbiochem.2006.11.017

Nagaraj, R. S., Anand, K. P. (2017). Study of serum high sensitive C-Reactive protein and ferritin in preterm labor. International Journal of Clinical Biochemistry and Research, 4 (3), 213–215.

De Jong, E. P., de Haan, T. R., Kroes, A. C. M., Beersma, M. F. C., Oepkes, D., Walther, F. J. (2006). Parvovirus B19 infection in pregnancy. Journal of Clinical Virology, 36 (1), 1–7. doi: 10.1016/j.jcv.2006.01.004

Crane, J., Mundle, W., Boucoiran, I., Gagnon, R., Bujold, E., Basso, M. et. al. (2014). Parvovirus B19 Infection in Pregnancy. Journal of Obstetrics and Gynaecology Canada, 36 (12), 1107–1116. doi: 10.1016/s1701-2163(15)30390-x

Bonvicini, F., Bua, G., Gallinella, G. (2017). Parvovirus B19 infection in pregnancy – awareness and opportunities. Current Opinion in Virology, 27, 8–14. doi: 10.1016/j.coviro.2017.10.003

Karabulut, A., Gok, S., Kocyigit, A. (2013). Non-immune hydrops fetalis without anemia due to parvovirus B19. International Journal of Gynecology & Obstetrics, 124 (1), 82. doi: 10.1016/j.ijgo.2013.07.021

Hvilsom, G., Thorsen, P., Jeune, B., Bakketeig, L. (2002). C-reactive protein: a serological marker for preterm delivery? Act a Obstetricia et Gynecologica Scandinavica, 81 (5), 424–429. doi: 10.1034/j.1600-0412.2002.810509.x

Shah, J., Baxi, B. (2016). Identification of biomarkers for prediction of preterm delivery. Journal of Medical Society, 30 (1), 3–14. doi: 10.4103/0972-4958.175790

Rebrova, O. Y. (2006). Statisticheskiy analiz medicinskih dannih: primenenie paketa prikladnuh program Statistica. Moscow: Mediasfera, 312.

DOI: http://dx.doi.org/10.21303/2504-5679.2018.00604


  • There are currently no refbacks.

Copyright (c) 2018 Natalia Bondarenko

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)